Jenburkt Pharmaceuticals Limited (BSE: 524731)
Health Care · Pharmaceuticals · IN
Rs945.00
+2.12% today · -12.8% 1Y
Jenburkt Pharmaceuticals Limited (BSE: 524731) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $43.09M.
Over the last twelve months the share price has lost 12.8%, trading between 880.10 and 1.32K.
Tweenvest scores Jenburkt Pharmaceuticals Limited across four factors: quality 83/100, value 49/100, growth 42/100, dividend 81/100. Its strongest factor is quality.
524731 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.09M
- Revenue (TTM)
- $17.84M
- P/E
- 12.70
- EPS
- 74.39
- Dividend yield
- 2.19%
- Beta (5Y)
- 0.39
- 52-week high
- Rs1,321.00
- 52-week low
- Rs880.10
- Avg volume (3M)
- —
- Shares outstanding
- 4.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Entropy Neurodynamics LimitedASX: EX1 | $43.32M | AU$— | — |
| Entropy Neurodynamics LimitedASX: ENP | $43.32M | AU$0.04 | -2.56% |
| Avecho Biotechnology LimitedASX: AVE | $43.14M | AU$0.02 | -20.00% |
| Decibel Cannabis Company Inc.TSXV: DB | $43.14M | CA$1.60 | -4.76% |
| Sofgen Pharma S.A.OTCPK: PROC.F | $43.07M | $— | — |
| Medicamen Biotech LimitedBSE: 531146 | $42.79M | Rs305.35 | -3.16% |
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.48M | JD3.17 | -0.63% |
| Tsubota Laboratory IncorporatedTSE: 4890 | $42.35M | ¥260.00 | +3.59% |
Figures last refreshed Oct 11, 2026.